Cargando…
Loss of Nrf2 abrogates the protective effect of Keap1 downregulation in a preclinical model of cutaneous squamous cell carcinoma
Cutaneous squamous cell carcinomas (cSCC) are the most common and highly mutated human malignancies, challenging identification of driver mutations and targeted therapies. Transcription factor NF-E2 p45-related factor 2 (Nrf2) orchestrates a cytoprotective inducible program, which counteracts the da...
Autores principales: | Knatko, Elena V., Higgins, Maureen, Fahey, Jed W., Dinkova-Kostova, Albena T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877584/ https://www.ncbi.nlm.nih.gov/pubmed/27216826 http://dx.doi.org/10.1038/srep25804 |
Ejemplares similares
-
KEAP1 and done? Targeting the NRF2 pathway with sulforaphane
por: Dinkova-Kostova, Albena T., et al.
Publicado: (2017) -
The isoquinoline PRL-295 increases the thermostability of Keap1 and disrupts its interaction with Nrf2
por: Dayalan Naidu, Sharadha, et al.
Publicado: (2021) -
Downregulation of Keap1 Confers Features of a Fasted Metabolic State
por: Knatko, Elena V., et al.
Publicado: (2020) -
The Role of Sulfhydryl Reactivity of Small Molecules for the Activation of the KEAP1/NRF2 Pathway and the Heat Shock Response
por: Dinkova-Kostova, Albena T.
Publicado: (2012) -
Monitoring Keap1–Nrf2 interactions in single live cells
por: Baird, Liam, et al.
Publicado: (2014)